Clinical characteristics of gastric Dieulafoy's lesion and risk factors for rebleeding of 111 patients
10.3969/j.issn.1007-1989.2017.04.008
- VernacularTitle:111例胃Dieulafoy病出血临床特征及再出血危险因素分析
- Author:
Qiang WANG
;
Shunhua LONG
;
Weixiao HU
;
Xu SHU
;
Bimin LI
;
Wangdi LIAO
;
Guilian LAN
;
Xuan ZHU
;
Nonghua Lü
;
Youxiang CHEN
- Keywords:
dieulafoy's lesion;
clinical characteristics;
endoscopy;
rebleeding;
risk factors
- From:
China Journal of Endoscopy
2017;23(4):43-48
- CountryChina
- Language:Chinese
-
Abstract:
Objective Dieulafoy's lesion is a rare cause of upper gastrointestinal bleeding. The purpose of this study was to recognize the clinical characteristics of gastric Dieulafoy and to identify possible predictive factors of rebleeding. Methods Retrospective study of patients with gastrointestinal bleeding secondary to Dieulafoy's lesion from January 2009 to June 2016. We analyzed the clinical data and endoscopic findings and the correlated with rebleeding risk factors with Dieulafoy's lesion. Results 111 patients were included in the study, 97 (87.4%) patients were male; the most common location of the bleeding lesions were Proximal stomach of 53 cases (47.7%); According to the Forrest type, 46.8% of the cases were arterial (spurting), 52.3% of the cases were arterial (oozing), there were 101 (91.0%) patients treated by endoscopic combined drug therapy. The success rate of Endoscopic hemostatic treatment was 84.2%, endoscopic hemostatic treatment success rate was as follows: single endoscopic, 85.0%; two endoscopic, 84.8%; three endoscopic, 75.0%. The hemostatic treatment success rate of 101 patients with endoscopic combined drug was as follows: Proximal stomach, 83.7%; mid-stomach, 82.1%; and distal stomach, 88.9%. Age (P = 0.002) and blood transfusion (P = 0.004) were risk factors for rebleeding in the study. Blood transfusion was associated with a higher recurrence rate for bleeding (P = 0.018, OR=37.77, 95% CI = 1.86~766.47) for 101 patients with endoscopic in combination with drug. Conclusion Endoscopic therapy is effective for treating Dieulafoy's lesion. The blood transfusion was associated with a high rate of bleeding recurrence. There were no significant differences between the rebleeding and non-rebleeding groups with respect to bleeding location or hemostatic methods.
